Search Results 821-830 of 18945 for Neutrophil

1. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

   - Absolute neutrophil count (ANC) ≥ 1,500/mm³ - Platelet count ≥ 100,000/mm³ - Hemoglobin (Hgb) ≥ 8.0 g/dL (transfusion or other intervention to achieve ...

2. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

   Leukocytes ≥3,000/mcL Absolute neutrophil count ≥1,500/mcL Platelets ≥100,000/mcL Total bilirubin ≤ 2.5 x limit of normal (ULN) AST(SGOT)/ALT(SGPT) ≤5 ...

3. Short-course Radiation Therapy for Hepatocellular Carcinoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000 cells/mm^3;; Patelets (Plt) ≥ 30,000 cells/mm^3 (the use of transfusion or other intervention to achieve the minimum ...

4. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1.5 x 109/L. Platelets ≥100 x 109/L. Life expectancy estimated at ≥3 months. Exclusion Criteria: Anti-cancer chemotherapy ...

5. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count 50,000/mm^3 or > 30,000/mm^3 if bone marrow plasma cells percentage > 50% by morphology. (No ...

6. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) AND aspartate ...

7. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 109/L,; Hemoglobin (Hgb) ≥ 90 g/L,; Platelets (plt) ≥ 100 x 109/L,; Potassium within normal range, or correctable ...

8. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelets ≥100,000/dL · Hemoglobin ≥9 g/dL · Bilirubin ≤1.5 mg/dL · Serum creatinine ≤ ...

9. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Hemoglobin ≥ 9 g/dL;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...

10. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors - Mayo Clinic

    Peripheral absolute neutrophil count (ANC) ≥ 1,000/μL; Platelet count ≥ 100,000/μL (transfusion independent); Hemoglobin ≥ 8.0 g/dL (may receive red blood ...